Cargando…
Human Nonalcoholic Steatohepatitis on a Chip
Nonalcoholic steatohepatitis (NASH), an advanced stage of nonalcoholic fatty liver disease (NAFLD), is a rapidly growing and global health problem compounded by the current absence of specific treatments. A major limiting factor in the development of new NASH therapies is the absence of models that...
Autores principales: | Freag, May S., Namgung, Bumseok, Reyna Fernandez, Maria E., Gherardi, Ermanno, Sengupta, Shiladitya, Jang, Hae Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850303/ https://www.ncbi.nlm.nih.gov/pubmed/33553970 http://dx.doi.org/10.1002/hep4.1647 |
Ejemplares similares
-
Γ-Aminobutyric acid promotes methionine-choline deficient diet-induced nonalcoholic steatohepatitis
por: Seok Roh, Yoon, et al.
Publicado: (2017) -
Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015) -
Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
por: Choi, Naeun, et al.
Publicado: (2019) -
The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017) -
A 3D Human Liver Model of Nonalcoholic Steatohepatitis
por: Duriez, Marion, et al.
Publicado: (2020)